Bioorganic and Medicinal Chemistry Letters p. 3081 - 3086 (1998)
Update date:2022-07-31
Topics:
Kuo, Michelle S.
Bock, Mark G.
Freidinger, Roger M.
Guidotti, Maribeth T.
Lis, Edward V.
Pawluczyk, Joseph M.
Perlow, Debra S.
Pettibone, Douglas J.
Quigley, Amy G.
Reiss, Duane R.
Williams, Peter D.
Woyden, Carla J.
Structure-activity studies on the oxytocin antagonist 1 (L-371,257) have identified a new series of high affinity, receptor-selective OT antagonists in which the N-acetyl-4-piperidinyl ether terminus in 1 has been replaced with a 1-(aryl)ethoxy group.
View MoreMS( MAOSHENG )Chemical CO.,LTD
Contact:+86-519-82726678.82726378
Address:TAOXI INDUSTRY ZONE JINTAN
Contact:0086-21-80264647
Address:RM 202, NO 1602 West Zhongshan Rd, Shanghai, China
Taizhou Chemedir Biopharm-tech Co., Ltd
Contact:+86 523 86200218
Address:G09, No. 1 Avenue China Medical City, Taizhou,Jiangsu, China
Ningbo Tide Imp. & Exp. Co., Ltd.
Contact:+86-571-8993 7933; +86-571-8993 6453
Address:7/F Anno Domini Building, Tower South, 8 Qiu Shi Road,Hangzhou,China.
LIANYUNGANG YC FINE CHEMICAL CO., LTD
Contact:+86-518-858 99188
Address:Shangdong Modern Bldg, South Greenpark Road, Lianyungang, Jiangsu Pro. China
Doi:10.1016/S0040-4020(97)00697-2
(1997)Doi:10.1021/jo001710q
(2001)Doi:10.1021/ja01871a037
(1939)Doi:10.1021/ja971574f
(1997)Doi:10.1021/jm970085n
(1997)Doi:10.1021/acs.joc.8b01737
(2018)
